A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease
- 30 September 2003
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 143 (3), 357-362
- https://doi.org/10.1067/s0022-3476(03)00330-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 36 references indexed in Scilit:
- NF-κB Activation in Peripheral Blood Monocytes/Macrophages and T Cells during Acute Kawasaki DiseaseClinical Immunology, 2001
- Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex: TRANSFER FROM CD14 TO TLR4 AND MD-2Published by Elsevier BV ,2001
- The Monocyte/IgE Connection: May Polymorphisms in the CD14 Gene Teach Us about IgE Regulation?International Archives of Allergy and Immunology, 2001
- Polyclonal expansion of TCRBV2‐ and TCRBV6‐bearing T cells in patients with Kawasaki diseaseImmunology, 1999
- LPS-induced release of IL-1β, IL-6, IL-8, TNF-α and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoproteinCytokine, 1994
- Cytokines predict coronary aneurysm formation in Kawasaki disease patientsEuropean Journal of Pediatrics, 1993
- Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki diseaseThe Journal of Pediatrics, 1992
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Soluble interleukin‐2 receptors in children with kawasaki syndromeArthritis & Rheumatism, 1990
- Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesionsClinical Immunology and Immunopathology, 1990